Risk Communication Advisory Committee
Meeting on November 17, 2011, from 8 a.m. to 5 p.m. (Day 1 of 2)]
Agenda: On November 17, 2011, the committee will discuss results of a literature review (as required in the Patient Protection and Affordable Care Act (Pub. L. 111–148) about communicating quantitative risk and benefit information in prescription drug promotional labeling and print advertising, and will also receive a briefing on activities in FDA’s Office of Special Health Issues.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment